Bright Minds

#药闻简讯# $Bright Minds(DRUG)$ 宣布其 BMB-101 治疗失神性癫痫和发育性癫痫性脑病 (DEE) 患者的 II 期临床试验取得积极的顶线结果。
失神发作：持续时间≥3 秒的失神发作次数中位数减少了 73.1%，p = 0.012
DEE：主要运动性癫痫发作次数中位数减少 63.3%

$Bright Minds(DRUG)$ Bright Minds生物科学表示，BMB-101第二期试验结果显示癫痫发作“显著”减少

1月6日，Bright Minds Biosciences $Bright Minds(DRUG)$ 宣布，其在研癫痫治疗药物在 II 期 BREAKTHROUGH 研究的两个患者队列中均达到了主要终点，受此消息提振，该公司股价上涨超过 16%。网页链接
这家生物科技公司正在开发选择性 5-HT2C 受体激动...

$Bright Minds(DRUG)$ F-X Appointment of Agent for Service of Process and Undertaking Accession Number: 0001437749-25-038731  Act: 33  Size: 36 KB 网页链接

$Bright Minds(DRUG)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001062993-25-016909  Act: 34  Size: 43 KB 网页链接

$Bright Minds(DRUG)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001062993-26-000089  Act: 33  Size: 430 KB 网页链接

$Bright Minds(DRUG)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001214659-25-016262  Act: 34  Size: 9 KB 网页链接

$Bright Minds(DRUG)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001062993-26-000098  Act: 34  Size: 4 MB 网页链接

$Bright Minds(DRUG)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001062993-26-000136  Act: 33  Size: 401 KB 网页链接

$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001062993-26-000151  Act: 34  Size: 22 KB 网页链接

$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0002060755-26-000007  Act: 34  Size: 25 KB 网页链接

$Bright Minds(DRUG)$ 40-F Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)] Accession Number: 0001437749-25-038729  Act: 34  Size: 9 MB 网页链接

$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001062993-25-016913  Act: 34  Size: 33 KB 网页链接

$Bright Minds(DRUG)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-111137  Act: 34  Size: 21 KB 网页链接

$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0002060755-26-000005  Act: 34  Size: 30 KB 网页链接

$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0002060755-26-000009  Act: 34  Size: 26 KB 网页链接

$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001062993-26-000138  Act: 34  Size: 267 KB 网页链接

$Bright Minds(DRUG)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-26-000518  Act: 34  Size: 10 KB 网页链接

$Bright Minds(DRUG)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-004874  Act: 34  Size: 15 KB 网页链接

$Bright Minds(DRUG)$ Vivo Opportunity Fund Holdings, L.P.、Vivo Opportunity, LLC、Vivo Opportunity Cayman Fund, L.P.及Vivo Opportunity Cayman, LLC联合提交了13G表格，披露其合计持有Bright Minds Biosciences Inc. 7.1%的股权。文件显示，Vivo Opportunity Fund Holdings持有454,184股普...